Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

被引:20
|
作者
Mezheyeuski, Artur [1 ,2 ]
Hrynchyk, Ina [3 ]
Karlberg, Mia [1 ]
Portyanko, Anna [2 ]
Egevad, Lars [1 ]
Ragnhammar, Peter [1 ]
Edler, David [4 ]
Glimelius, Bengt [5 ]
Ostman, Arne [1 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Belarusian State Med Univ, Dept Pathol, Minsk, BELARUS
[3] City Clin Pathologoanat Bur, Minsk, BELARUS
[4] Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Stockholm, Sweden
[5] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
瑞典研究理事会;
关键词
THYMIDYLATE SYNTHASE EXPRESSION; COLORECTAL-CANCER; ADJUVANT THERAPY; MISMATCH REPAIR; FLUOROURACIL; CHEMOTHERAPY; INTERFACE; PATTERN; BENEFIT; MARKER;
D O I
10.1038/srep36149
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The complexity of tumor histomorphology reflects underlying tumor biology impacting on natural course and response to treatment. This study presents a method of computer-aided analysis of tissue sections, relying on multifractal (MF) analyses, of cytokeratin-stained tumor sections which quantitatively evaluates of the morphological complexity of the tumor-stroma interface. This approach was applied to colon cancer collection, from an adjuvant treatment randomized study. Metrics obtained with the method acted as independent markers for natural course of the disease, and for benefit of adjuvant treatment. Comparative analyses demonstrated that MF metrics out-performed standard histomorphological features such as tumor grade, budding and configuration of invasive front. Notably, the MF analyses-derived "alpha(max)" -metric constitutes the first response-predictive biomarker in stage II-III colon cancer showing significant interactions with treatment in analyses using a randomized trial-derived study population. Based on these results the method appears as an attractive and easy-to-implement tool for biomarker identification.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
    Artur Mezheyeuski
    Ina Hrynchyk
    Mia Karlberg
    Anna Portyanko
    Lars Egevad
    Peter Ragnhammar
    David Edler
    Bengt Glimelius
    Arne Östman
    Scientific Reports, 6
  • [2] Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer
    Xu, Yansong
    Liang, Fangfang
    Chen, Yi
    Wang, Zhen
    Zhong, Huage
    Tang, Weizhong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [3] Wnt5a expression and prognosis in stage II-III colon cancer
    Lund, Cecilia Margareta
    Dyhl-Polk, Anne
    Nielsen, Dorte Lisbeth
    Riis, Lene Buhl
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [4] Stage II-III colon cancer: a comparison of survival calculators
    Lemini, Riccardo
    Attwood, Kristopher
    Pecenka, Stacey
    Grego, Juliet
    Spaulding, Aaron C.
    Nurkin, Steven
    Colibaseanu, Dorin T.
    Gabriel, Emmanuel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1091 - 1098
  • [5] Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II-III colon cancer
    Jiang, Wei
    Wang, Huaiming
    Chen, Weisheng
    Zhao, Yandong
    Yan, Botao
    Chen, Dexin
    Dong, Xiaoyu
    Cheng, Jiaxin
    Lin, Zexi
    Zhuo, Shuangmu
    Wang, Hui
    Yan, Jun
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (03)
  • [6] Treatment of Stage II-III Rectal Cancer Patients
    Kim, Miranda B.
    Hong, Theodore S.
    Wo, Jennifer Y.
    CURRENT ONCOLOGY REPORTS, 2014, 16 (01)
  • [7] Prognostic relevance of Src activation in stage II-III colon cancer
    Martinez-Perez, Julia
    Lopez-Calderero, Iker
    Saez, Carmen
    Benavent, Marta
    Limon, Maria L.
    Gonzalez-Exposito, Reyes
    Soldevilla, Beatriz
    Carmen Riesco-Martinez, Maria
    Salamanca, Javier
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    HUMAN PATHOLOGY, 2017, 67 : 119 - 125
  • [8] Neoadjuvant Treatment Approaches for Stage II-III Rectal Cancer
    Nurkin, Steven
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 572 - 575
  • [9] COMPREHENSIVE TREATMENT OF STAGE II-III BREAST-CANCER
    KHARCHENKO, VP
    PANSHIN, GA
    SOTNIKOV, VM
    KHMELEVSKY, EV
    SOVETSKAYA MEDITSINA, 1985, (02): : 89 - 92
  • [10] Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
    Penney, Kathryn L.
    Banbury, Barbara L.
    Bien, Stephanie
    Harrison, Tabitha A.
    Hua, Xinwei
    Phipps, Amanda I.
    Sun, Wei
    Song, Mingyang
    Joshi, Amit D.
    Alberts, Steven R.
    Allegra, Carmen J.
    Atkins, James
    Colangelo, Linda H.
    George, Thomas J.
    Goldberg, Richard M.
    Lucas, Peter C.
    Nair, Suresh G.
    Shi, Qian
    Sinicrope, Frank A.
    Wolmark, Norman
    Yothers, Greg
    Peters, Ulrike
    Newcomb, Polly A.
    Chan, Andrew T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2717 - +